Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population PK, efficacy and safety of ciprofol for pediatric cardiac anesthesia
ChiCTR2600118090Phase 4Completed
- Sponsor
- Department of Pharmacy, Qingdao Women and Children's Hospital
- Start
- Feb 2026
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ciprofol in Cardiovascular Malformation (CVM), sponsored by Department of Pharmacy, Qingdao Women and Children's Hospital. Primary endpoint: Induction time. Started Feb 2026; status: completed.
02
Drugs
ciprofol
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR2600118090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600118090.